Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,073 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunohistochemical expression of osteopontin in gastric cancer.
Imano M, Satou T, Itoh T, Sakai K, Ishimaru E, Yasuda A, Peng YF, Shinkai M, Akai F, Yasuda T, Imamoto H, Okuno K, Ito H, Shiozaki H, Ohyanagi H. Imano M, et al. Among authors: sakai k. J Gastrointest Surg. 2009 Sep;13(9):1577-82. doi: 10.1007/s11605-009-0955-y. Epub 2009 Jul 7. J Gastrointest Surg. 2009. PMID: 19582521
Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective study.
Hirashima T, Nagai T, Shigeoka H, Tamura Y, Yoshida H, Kawahara K, Kondoh Y, Sakai K, Hashimoto S, Fujishima M, Shiroyama T, Tamiya M, Morishita N, Suzuki H, Okamoto N, Kawase I. Hirashima T, et al. Among authors: sakai k. BMC Cancer. 2014 Oct 18;14:770. doi: 10.1186/1471-2407-14-770. BMC Cancer. 2014. PMID: 25326267 Free PMC article.
Assessment of heterogeneity according to hospital or medical experience factors in outcomes of chemotherapy for advanced biliary tract cancer: a post-hoc analysis of JCOG1113.
Fukushi K, Imaoka H, Ikeda M, Mizusawa J, Morizane C, Okusaka T, Kobayashi S, Sasahira N, Shimizu S, Yamazaki K, Okano N, Miwa H, Hara K, Satoi S, Sano K, Sakai K, Sugimoto R, Nakamura K, Terashima T, Ozaka M, Ueno M; JCOG Hepatobiliary and Pancreatic Oncology Group. Fukushi K, et al. Among authors: sakai k. Jpn J Clin Oncol. 2025 Jan 8:hyae188. doi: 10.1093/jjco/hyae188. Online ahead of print. Jpn J Clin Oncol. 2025. PMID: 39775866
Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease.
Shin D, Galougahi KK, Singh M, Caron E, Cannata M, Ciftcikal Y, Gujja M, Sakai K, Moses J, Shlofmitz R, Al-Azizi K, Doshi D, Jeremias A, Shlofmitz E, Ali ZA. Shin D, et al. Among authors: sakai k. Prog Cardiovasc Dis. 2025 Jan 4:S0033-0620(24)00173-7. doi: 10.1016/j.pcad.2024.12.004. Online ahead of print. Prog Cardiovasc Dis. 2025. PMID: 39761789 Review.
Ghrelin-LEAP2 interactions along the stomach-liver axis.
Sakai K, Nakazato Y, Shiimura Y, Zhang W, Nakazato M. Sakai K, et al. Endocr J. 2024 Dec 27. doi: 10.1507/endocrj.EJ24-0543. Online ahead of print. Endocr J. 2024. PMID: 39756956 Free article.
Validation of contemporary methods to assess vessel specific myocardial mass.
Tajima A, Stalikas N, Belmonte M, Sakai K, Pijls N, Keulards DCJ, Sonck J, Astudillo P, Wilgenhof A, Bouisset F, Munhoz D, De Bruyne B, Collet C. Tajima A, et al. Among authors: sakai k. Cardiovasc Revasc Med. 2024 Dec 6:S1553-8389(24)00743-7. doi: 10.1016/j.carrev.2024.11.011. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 39753396 No abstract available.
5,073 results